Techniques like mass spectrometry, while highly accurate, may not be practical for field use, however, these biomarkers could be translated into rapid diagnostic tests for field use
Key lipid changes with GLP-1 receptor agonists include: Triglycerides: 15-25% reduction Total cholesterol: 3-8% reduction LDL cholesterol: 3-7% reduction HDL cholesterol: 2-5% increase Non-HDL cholesterol: 5-10% reduction The SELECT cardiovascular outcomes trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in patients with established cardiovascular disease who were receiving standard background care
Repeated injection at the same location causes lipohypertrophy, a condition where the subcutaneous tissue thickens and hardens into lumps
GLP-1s can be taken alone or with other medications, including insulin, metformin, and SGLT-2 inhibitors
Garca-Gimnez JL, Rom-Mateo C, Prez-Machado G, Peir-Chova L, Pallard FV (2017) Role of glutathione in the regulation of epigenetic mechanisms in disease
